Guideline-based management of asthma focuses on disease severity and choosing the
appropriate medical therapy to control symptoms and reduce the risk of exacerbations …

Background The proliferation of inhaler devices has resulted in a confusing number of
choices for clinicians who are selecting a delivery device for aerosol therapy. There are …

Asthma is a serious health problem throughout the world. During the past two decades,
many scientific advances have improved our understanding of asthma and ability to manage …

Background β-Adrenergic agonists exert physiologic effects that are the opposite of those of
β-blockers. β-Blockers are known to reduce morbidity and mortality in patients with cardiac …

All patients with asthma are at risk of having exacerbations. Hospitalizations and emergency
department (ED) visits account for a large proportion of the health-care cost burden of …

Abstract The Saudi Initiative for Asthma 2021 (SINA-2021) is the fifth version of asthma
guidelines for the diagnosis and management of asthma for adults and children, which is …

Despite the use of effective medications to control asthma, severe exacerbations in asthma
are still a major health risk and require urgent action on the part of the patient and physician …

Asthma is a prevalent chronic disease of the respiratory system and acute asthma
exacerbations are among the most common causes of presentation to the emergency …

Background Patients with acute asthma treated in the emergency department are frequently
treated with intermittent inhaled beta‐agonists delivered by nebulisation. The use of …

Acute exacerbations of asthma can lead to respiratory failure requiring ventilatory
assistance. Noninvasive ventilation may prevent the need for endotracheal intubation in …